Herein, we demonstrated that half-life extension, by the fusion of an ABD to the C-terminus of an anti-HER2 nanobody, resulted in prolonged and homogeneous tumor accumulation, accompanied by reduced kidney retention. Here, ERBB2 is linked to neoplasm.